ArticleDermatology practical & conceptual2026

Effectiveness and Safety of Deucravacitinib in Moderate-to-Severe Psoriasis: an Italian Multicenter Real-Life Study in the Lazio Region.

Annunziata Dattola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.